Harvard Business Review

AUGUST 3, 2012

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. Historically, big pharma firms made their own drugs.

Licensing 12

Licensing Depreciation Pharmaceuticals Budgeting 12

Harvard Business Review

SEPTEMBER 5, 2016

The idea isn’t new — it’s well established in online advertising, for example — but its application is becoming more widespread in the private and public sectors. Consider these examples: Education. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JULY 4, 2017

’ One could imagine an Apple car that is a Tesla-like product—one with comparable speed, self-driving technology, aesthetics, and features–but is so seamlessly integrated with the Apple ecosystem and requires a new sized iPhone, or some kind of blend of iPhone, iPad or MacBook. How about a man cave on wheels? Or a kitchen?

Transportation 8

Transportation Sports Pharmaceuticals Health Care 8

Harvard Business Review

AUGUST 2, 2011

Take, for example, the debate over economic competition between China and the U.S. In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. But at the economic level, competition is much more nuanced and even muted.

Apparel 14

Apparel Pharmaceuticals Finance Licensing 14

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. without any compliance process or technology in place.".

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

AUGUST 29, 2011

"There's a sense that a woman is just working until she gets married, [that] she is not a long-term resource," said one senior finance professional. For example, Infosys, the Bangalore-based info-tech powerhouse, offers the Infosys Women's Inclusivity Network (IWIN). Some Indian companies are taking steps to help these stressed women.

Stress 13

Stress Human Resources Pharmaceuticals Sharpe 13

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 10, 2013

Corporate R&D too often focuses on refining technologies that are already in use. In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Get a Lawyer.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

Corporate R&D too often focuses on refining technologies that are already in use. In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

SEPTEMBER 13, 2011

Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago. In other words, changes in sales results may not be a sufficient measure of current performance.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

FEBRUARY 4, 2013

The financial crisis is a prime example of too few people holding the reins. For example, the rapidly evolving field of biomimicry examines nature's models and processes to help solve human problems. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

JANUARY 26, 2011

The exchange has already established listing requirements for responsibility reporting, for example. Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. environmental, social and governance) metrics relevant to long-term sustainable corporate performance.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

MAY 5, 2016

sanctions are delaying these projects being financed. more competition to reduce consumer prices, sharing international best practices, technology transfer, public-private partnerships) needed to boost the economy’s health. However, remaining U.S. financial system for bank transactions related to Iran.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

MARCH 24, 2011

In the early 1980s, for example, at least some partners — Bob Waterman, co-author of In Search of Excellence , among them — counseled gradual, quiet expansion, this to maintain the top-flight quality of the consultancy's people and its work. Was it only ten years ago that the profits of the top 10 U.S.

McKinsey 13

McKinsey Consultative Waterman Intellectual Capital 13

Harvard Business Review

FEBRUARY 20, 2014

You can read about it in recent issues of The Economist , The New York Times , and in the book The Second Machine Age by Erik Brynjolfsson and Andrew McAfee of the Massachusetts Institute of Technology. The arguments are familiar. We can and do make all of that (although not very many phones and hardly any clothing or shoes).

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. The data captured a 20-year period, from 1995 to 2014. However, classifications were mostly clear.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. My favorite example of this is iRobot , the maker of the innovative Roomba vacuum.

Productivity 8

Productivity Products Company Engineering 8

Mills Scofield

NOVEMBER 11, 2014

This is taken from The Intercollegiate Finance Journal (IFJ) is an undergraduate student-run journal about how current finance, economics, business and technology issues affect students'' lives. Pfizer’s CEO, for example, is British. Corporate Mythology. Decrying tax inversion as unpatriotic misses the point.

Finance 131

Finance Incentives Education Pharmaceuticals 131

Harvard Business Review

DECEMBER 12, 2018

A new generation of philanthropists, whose wealth was created via entrepreneurship in technology-driven fields, has the unique opportunity to make a real difference in speeding the pace of progress in the fight against cancer. One timely example illustrates the point. Luxy Images/Getty Images.

Pharmaceuticals 8

Pharmaceuticals Venture Funding Finance Development 8